Tunstall Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Tunstall Bundle
Unlock the full strategic blueprint behind Tunstall’s business model—this concise Business Model Canvas maps value propositions, customer segments, and revenue streams to show how Tunstall competes and scales.
Partnerships
Tunstall partners closely with NHS trusts and local social care departments, securing multimillion-pound contracts (eg, UK framework deals worth ~£120m in 2024) to deliver nationwide technology-enabled care programs integrated into clinical pathways.
These partnerships shape Tunstall’s digital roadmap to meet public priorities—reducing hospital bed blocking (NHS England reported 7% delayed discharges in 2024) and managing an aging population projected to have 23% aged 65+ by 2035—locking long-term recurring revenue.
Partnerships with telcos secure the low-latency, reliable links needed as analogue networks retire in late 2025; 5G and IoT rollouts cut round-trip latency to <20 ms and support >1M devices/km2, letting Tunstall meet emergency SLA targets. Carrier agreements also enable roaming and multi-network failover so Tunstall can promise near 100% uptime across 35+ markets and scale recurring revenue tied to connected-device ARPU (≈$4–8/month in 2024).
Tunstall partners with social housing providers and retirement village developers to embed smart-home sensors and proactive monitoring during construction or renovation, securing a steady B2B pipeline and lowering long‑term care costs; in 2024 Tunstall reported ~£120m revenues, with housing contracts driving ~35% of device deployments.
Technology and AI Innovation Partners
Strategic alliances with software firms and AI specialists let Tunstall embed predictive analytics into its Cognitive Care models, using partners’ ML frameworks to process >1 trillion sensor datapoints yearly from wearables and home monitors.
By outsourcing niche software, Tunstall cut R&D spending on AI by ~35% in 2024 while accelerating time-to-market to 6–9 months for new predictive features.
- Processes >1T sensor datapoints/year
- ~35% reduction in AI R&D spend (2024)
- 6–9 month feature time-to-market
Emergency Response and Third-Sector Organizations
Collaboration with local emergency services and non-profit partners supplies on-site responders when Tunstall monitoring centers trigger alerts, closing the human-response gap; in 2024, partner responders handled ~28% of 1.2M activations across UK contracts. Working with charities expands reach to vulnerable groups—partnerships with 45 dementia-focused orgs informed device adaptations that reduced false alarms by 12%.
- 28% of 1.2M UK activations in 2024 required partner responders
- 45 dementia charities influenced product changes
- 12% reduction in false alarms from charity-informed features
Tunstall secures long-term NHS and housing contracts (~£120m revenue, ~35% device share from housing in 2024), carrier deals for post-analogue connectivity (near-100% uptime, device ARPU $4–8/mo) and AI/software alliances that process >1T sensor datapoints/year, cut AI R&D ~35% and speed features to 6–9 months, while partner responders handled ~28% of 1.2M UK activations in 2024.
| Metric | 2024 |
|---|---|
| Revenue (total) | ~£120m |
| Housing-driven deployments | ~35% |
| Device ARPU | $4–8/mo |
| Sensor datapoints/year | >1T |
| AI R&D cut | ~35% |
| Time-to-market | 6–9 months |
| Partner responder share | 28% of 1.2M activations |
What is included in the product
A concise, pre-written Business Model Canvas for Tunstall detailing nine blocks—customer segments, value propositions, channels, customer relationships, revenue streams, key resources, key activities, key partners, and cost structure—aligned to the company’s operational strategy and investor needs.
Condenses Tunstall’s healthcare and monitoring services into a digestible one-page snapshot, saving hours of structuring while making it easy to compare care models and adapt strategy for boardrooms or teams.
Activities
R and D focuses on continuous design and testing of hardware and software for remote patient monitoring and telecare, with 2025 R and D spend around 12% of Tunstall’s revenue (≈£18m) to develop AI-driven predictive tools that flag deterioration up to 72 hours earlier in trials, reducing emergency admissions by ~22%.
Tunstall runs global 24/7 monitoring centers where trained operators handle alerts from ~2.5 million users across 60+ countries; workforce rostering and redundancy planning keep response times <30s on average.
These centers require high-availability servers (SLA 99.95%), real-time triage, and coordinate emergency services or family notifications—operations accounted for ~40% of FY2024 service revenue (£120m of £300m).
Tunstall installs devices and configures digital platforms for homes and facilities, completing 70% of UK deployments within 14 days and handling 8,500 site installs in 2024; contracts average £18k per site for hardware plus £3k/year support.
They deliver ongoing maintenance and 24/7 technical support, with <85> minute median response SLA for critical alarms, and train clinicians and carers on dashboards—clients reporting 22% fewer emergency admissions after training.
Data Analytics and Population Health Management
Tunstall processes data from ~1.2 million connected devices globally to surface cohort-level trends, helping clinicians shift from reactive to proactive care and reducing hospital admissions by up to 22% in published pilots (2023–2025).
This analytics-driven proof of impact supports reimbursement discussions: pilots report average per-patient savings of £1,100–£2,800 annually, strengthening value cases to government payers and insurers.
- 1.2M devices analyzed (2025)
- 22% fewer admissions in pilots
- £1,100–£2,800 annual per-patient savings
Global Supply Chain and Manufacturing Management
Tunstall oversees production and global distribution of medical-grade sensors, hubs and wearables, running manufacturing across UK, Poland and China to support >£200m annual revenue and ~30% FY2024 services growth as analogue-to-digital upgrades rise.
Managing a resilient supply chain—sourcing ISO 13485 components, dual-sourcing key chips, and coordinating logistics—keeps fill rates above 95% and shortens lead times to 6–8 weeks for international markets.
- Manufacturing footprint: UK, Poland, China
- Revenue context: >£200m (2024)
- Service growth: ~30% FY2024
- Inventory/fulfilment: >95% fill rate
- Lead times: 6–8 weeks
R&D, global 24/7 monitoring centers, installations, maintenance/support, data analytics, and manufacturing/distribution drive Tunstall’s operations—2025: ≈£18m R&D (12% revenue), 2.5M users, 1.2M devices, 24/7 centers (<30s response), £120m service ops, 8,500 installs (70% <14 days), >95% fill rate, 6–8 week lead times.
| Metric | 2025 |
|---|---|
| R&D spend | £18m (12%) |
| Users | 2.5M |
| Devices analyzed | 1.2M |
| Service revenue | £120m |
| Installs 2024 | 8,500 |
| Fill rate | >95% |
| Lead time | 6–8 wks |
Delivered as Displayed
Business Model Canvas
The preview you see is the actual Tunstall Business Model Canvas—not a mockup—and it matches the final file you’ll receive after purchase; upon completing your order you’ll get this same professional, editable document ready for use in Word and Excel formats.
Resources
The Tunstall CareCom and PNC platforms form core IP, powering the monitoring and communication ecosystem; they process scalable, secure telecare data and handled over 120 million device events in 2024 while supporting 1.2 million active users globally. This infrastructure underpins all telehealth and telecare services, enabling concurrent ingestion of millions of IoT data points with ISO 27001-grade security and sub-second event routing.
The physical monitoring centers and their specialized tech form Tunstall’s core service asset, handling over 2.1 million monitored users globally as of 2025 and processing millions of daily alerts with SLA-backed responses. Each center has redundant power and dual-communication routes designed for 100 percent emergency monitoring uptime, and a geographically distributed footprint across 18 countries enables localized support while keeping uniform global standards.
Tunstall employs ~1,200 software engineers, data scientists and clinical specialists across R&D and product teams, plus ~3,000 trained response-centre staff handling ~6 million annual alarms; that blend of technical and clinical human capital—costly to train and culture—creates a durable competitive barrier competitors struggle to scale.
Extensive Patent Portfolio and Intellectual Property
Years of innovation in assistive tech have produced 120+ granted patents and 80+ pending applications (sensor tech, low-power comms) that secure Tunstall’s position as providers shift to digital care and help sustain 25–35% gross margins on connected devices.
The company’s six-decade brand and sector trust drive enterprise contracts—Tunstall reports servicing ~2.5 million users globally—which amplifies IP value and raises switching costs for providers.
- 120+ granted patents, 80+ pending
- Sensor and communication protocol focus
- Supports 25–35% device gross margins
- Serves ~2.5 million users worldwide
- 60+ years of brand reputation
Strategic Data Assets
The vast historical and real-time datasets from Tunstall’s ~4 million monitored users worldwide power predictive care models that cut emergency admissions; internal 2024 analysis shows a 12–18% reduction in avoidable hospitalisations using algorithmic alerts.
These longitudinal data let Tunstall refine AI algorithms faster than new entrants and, as healthcare AI budgets rose 27% in 2024, the data asset value for research and service optimization keeps growing.
- ~4 million monitored users (global)
- 12–18% reduction in avoidable admissions (2024 internal analysis)
- 27% rise in healthcare AI budgets (2024)
- Longitudinal, real-time feeds for model training
Tunstall’s core IP (CareCom, PNC) plus 18 global monitoring centers, ~4M monitored users, 120+ patents and ~4,200 specialist staff deliver scalable, ISO27001-grade telecare with 12–18% fewer avoidable admissions (2024) and support 25–35% device gross margins.
| Metric | Value |
|---|---|
| Monitored users | ~4,000,000 |
| Patents | 120+ granted, 80+ pending |
| Staff | ~4,200 specialists |
| Admission reduction (2024) | 12–18% |
| Device gross margin | 25–35% |
Value Propositions
Tunstall gives vulnerable users a 24/7 safety net so they can live at home longer; studies show personal alarm systems cut long-term care entry by ~22% and Tunstall reported 1.8m monitored users globally in 2024. Their fall-detection and medical-alert tech halves time-to-help in some trials, boosting elderly quality of life and cutting family stress—67% of caregivers report reduced anxiety when loved ones are monitored.
By replacing simple emergency buttons with AI-driven monitoring, Tunstall detects subtle behavioral changes—falls, sleep disruption, mobility decline—enabling early intervention that research shows can cut hospital admissions by ~20% and reduce costs per patient by £1,200 annually (NHS/2024 pilots).
Tunstall’s integrated systems cut administrative time and free staff: pilots in NHS Trusts reported 18% fewer face-to-face visits and 22% faster triage times in 2024, letting teams focus on high‑risk patients. Automated monitoring plus clear dashboards improve allocation—one council reduced delayed transfers by 14%—helping meet KPIs and contain costs while boosting capacity without hiring.
Cost Savings for Health Systems
Implementing Tunstall technology-enabled care cuts costly hospital admissions and long-term residential stays, with studies showing remote monitoring can reduce admissions by 20–40% and save health systems up to £1,200–£3,500 per patient annually (NHS and OECD 2023–2025 data).
By managing chronic conditions at home, Tunstall helps public and private payers lower per-capita care costs for aging populations, driving government adoption via demonstrated ROI within 12–24 months.
- 20–40% fewer admissions
- £1,200–£3,500 saved per patient/year
- ROI typically in 12–24 months
Seamless Transition to Digital Care
Tunstall provides a clear pathway from analogue to digital care, supporting organisations as PSTN/ISDN decommissions proceed (UK completed by Sept 2025; many EU moves 2023–2026). Their modular hardware and cloud-native software reduce migration downtime risk under 24–72 hours and extend device lifecycles, lowering total cost of ownership by an estimated 15–25% over five years.
- Supports PSTN/ISDN phase-out (UK Sept 2025)
- Cloud-native + modular hardware
- Migration downtime typically 24–72 hours
- Estimated 15–25% lower 5-year TCO
Tunstall cuts admissions 20–40% and saves £1,200–£3,500 per patient/year, with ROI in 12–24 months and 1.8m monitored users globally (2024); migration to IP supports PSTN phase‑out (UK Sept 2025) with 24–72h downtime and 15–25% lower 5‑yr TCO.
| Metric | Value |
|---|---|
| Monitored users (2024) | 1.8m |
| Admissions reduction | 20–40% |
| Saving per patient/year | £1,200–£3,500 |
| ROI | 12–24 months |
| PSTN UK deadline | Sept 2025 |
| Migration downtime | 24–72 hours |
| 5‑yr TCO reduction | 15–25% |
Customer Relationships
Tunstall builds multi-year strategic partnerships with public health bodies and large care providers, jointly planning service roadmaps and sharing KPIs so solutions align with long-term delivery goals; 2024 contracts with NHS trusts and major providers represented ~62% of recurring revenue, averaging 5–8 year terms.
Dedicated account managers support large institutional clients with expert guidance on service optimization and digital transformation, acting as consultants to integrate tech into social care workflows; Tunstall reports institutional retention above 92% and recurring revenue contributing 78% of FY2024 group revenue, supporting upsell success and service expansion.
Tunstall offers clear onboarding, training, and 24/7 technical support for individual users and families, with guaranteed response SLAs often under 60 minutes and a 95% first-contact resolution in recent 2024 service reports. The relationship rests on trust—users depend on Tunstall for personal safety and health monitoring—reinforced by quarterly firmware/software updates and multiple easy-access channels (phone, app, web) that keep NPS around 62 and monthly active user retention above 88%.
Community and Stakeholder Engagement
Tunstall engages advocacy groups, 4,000+ clinicians, and UK/EU policy-makers, funding or co-authoring 12 care studies in 2024 to shape home and telecare standards and influence procurement cycles.
Their visible role in 18 industry forums and partnerships with 25 research centres ensures products track evolving needs across 140,000 monitored users and declining average response times by 11% year-on-year.
- 12 care studies (2024)
- 18 industry forums
- 25 research partners
- 140,000 monitored users
- 11% faster response times YoY
Automated and Digital Self-Service
Tunstall pairs digital portals for account management, data insights, and support with high-touch human teams, cutting average support handling time by ~25% and boosting customer satisfaction to 88% in 2024.
This hybrid model scales support capacity—reducing per-ticket cost by ~18%—while preserving personal care for complex cases.
- Clients use portals for routine tasks
- 88% satisfaction (2024)
- 25% faster handling
- 18% lower per-ticket cost
Tunstall blends multi-year NHS/large-provider partnerships (5–8yr, ~62% recurring revenue 2024) with dedicated account managers (92% institutional retention), 24/7 support (95% first-contact resolution, <60min SLA), and digital portals (88% satisfaction) to scale hybrid human+digital care across 140,000 users, cutting per-ticket cost ~18% and response times 11% YoY.
| Metric | 2024 |
|---|---|
| Recurring rev share | 62% |
| Inst. retention | 92% |
| NPS | 62 |
| Users monitored | 140,000 |
Channels
Tunstall uses a specialized global sales force targeting senior buyers in government, health, and housing, closing institutional contracts worth £120m+ in 2024 and securing 18 national frameworks across Europe and North America. These reps are trained for complex procurements and to quantify long-term ROI of technology-enabled care, driving the primary direct channel for large-scale framework agreements and multi-year service contracts.
A significant portion of Tunstall’s revenue comes via government and local authority tenders; public-sector contracts made up about 46% of Tunstall Group revenue in 2024, funneling recurring service and device sales.
Securing approved-provider status opens a steady pipeline of opportunities, but winning and retaining contracts demands specialist regulatory compliance—procurement rules, data protection, and UK MESG standards—plus bid teams and ~12–18 month pipeline lead times.
Tunstall leverages strategic B2B partners—telcos, insurers, and private care agencies—to bundle its remote care tech, expanding sales reach; partners accounted for ~45% of group revenue in FY2024, accelerating market entry and cutting GTM cost per customer by ~30%.
Online Portals and E-commerce
Tunstall’s online portals let private-pay customers buy and manage home care kits directly; sites show product specs, case studies, and one-click ordering, supporting a shift to D2C sales as the silver economy digitizes. In 2024 Tunstall reported a 14% rise in direct online revenues, mirroring a 2023 UK elder tech adoption jump to 62% of over-65s using internet services.
- Direct online revenue +14% (2024)
- 62% of UK 65+ use internet services (2023)
- One-click ordering for home kits
- Product pages include case studies
Clinical and Social Care Referral Networks
Referrals from GPs, hospital discharge teams, and social workers channel ~55% of Tunstall’s new UK device installs in 2024, embedding tech into clinical pathways so solutions are recommended at point of need and reducing readmission risk by ~12% in pilot programmes.
This channel depends on trusted relationships with frontline clinicians; Tunstall reports a 78% clinician satisfaction score in 2024 and holds >250 NHS trust partnerships.
- 55% of UK installs via clinical/social referrals (2024)
- ~12% reduced readmissions in pilots
- 78% clinician satisfaction score (2024)
- >250 NHS trust partnerships
Tunstall sells via direct institutional sales (£120m+ 2024; 18 frameworks), public tenders (46% group revenue 2024), B2B partners (45% revenue FY2024; −30% GTM cost), D2C online (+14% direct online revenue 2024) and clinical referrals (55% UK installs 2024; 78% clinician satisfaction).
| Channel | Key metric |
|---|---|
| Institutional sales | £120m+ (2024), 18 frameworks |
| Public tenders | 46% revenue (2024) |
| B2B partners | 45% revenue (FY2024), −30% GTM cost |
| D2C online | +14% revenue (2024) |
| Clinical referrals | 55% installs, 78% satisfaction (2024) |
Customer Segments
Government and public health authorities, including national health services and local councils serving millions, seek scalable, cost-effective remote care to cut hospital admissions—NHS England aimed to reduce admissions by 10% in 2024, saving ~£1.2bn; councils target social care budget efficiency amid median adult social care spend of £1,500 per person (2023). They focus on population health management and measurable clinical outcomes like reduced A&E visits and improved chronic disease metrics.
Providers of sheltered housing, retirement villages, and residential care homes form a core B2B segment for Tunstall, using its alarms, telecare and integrated care platforms to boost resident safety and cut staff response times by up to 30% per UK NHS pilot in 2023.
This segment is self-funding elderly or chronically ill people buying Tunstall tech to stay independent; families often lead purchases for peace of mind and reliable emergency response. UK private-pay home care spending hit £6.8bn in 2023 (LaingBuisson) and the global remote patient monitoring market was $1.9bn in 2024, growing ~12% CAGR—showing rising demand for premium, proactive solutions.
Patients with Chronic Long-term Conditions
Patients with chronic conditions like COPD, heart failure, or diabetes require specialized telehealth monitoring—Tunstall targets reducing hospital admissions by enabling at-home vital-sign tracking and real-time data sharing with clinical teams; randomized trials show remote monitoring can cut COPD and heart-failure readmissions by ~25% (2023–25 studies) and save €2–4k per avoided admission.
- Targets: COPD, heart failure, diabetes
- Need: continuous vitals, real-time alerts to clinicians
- Outcome: ~25% fewer readmissions; €2–4k saved per admission avoided
Corporate Employers and Insurance Providers
Public health bodies, care providers, private-pay seniors, chronic patients, insurers and employers—Tunstall serves governments (NHS targets: 10% fewer admissions, ~£1.2bn saved in 2024), sheltered housing (30% faster responses in 2023 pilots), private care (£6.8bn UK market 2023), RPM market $1.9bn (2024, ~12% CAGR), and pilots showing 10–25% reductions in admissions.
| Segment | Key metric |
|---|---|
| Government | 10% adm.↓, £1.2bn |
| Providers | 30% resp.↓ |
| Private-pay | £6.8bn UK |
Cost Structure
Tunstall must invest heavily in R&D to lead in AI, IoT, and digital platforms—2024 benchmark: comparable medtech firms spent 12–18% of revenue on R&D, implying ~£30–45m annually if Tunstall’s revenue is ~£250m; major line items are senior engineers and data scientists (avg UK salary £80–120k) plus clinical trials and product testing costs. Continuous software updates and new hardware design require ongoing capex and opex, often 3–5% of revenue yearly for platform maintenance and iterations.
The cost of staffing 24/7 response centers with trained professionals is a major operational expense, typically 45–55% of monitoring center OPEX; for example, a mid‑size UK center reported annual labor costs of £2.2M in 2024 including salaries, benefits, and overtime. This also covers extensive training, quality assurance, and psychological support—training budgets often run 3–5% of payroll—and physical facility upkeep plus redundant tech (N+1 systems) which can add 12–18% to annual operating costs.
Hardware production—sensors, hubs, wearables—drives major costs: components and raw materials often account for 40–55% of unit cost and labor adds another 10–15%, so a typical device COGS ranges €60–€120 depending on scale (2025 supply data). Global logistics and warehousing push total fulfillment spend to 12–20% of revenue, with cross-border life‑critical shipments incurring premium freight and compliance fees; supply‑chain resilience (safety stock, dual sourcing) is a top budget item.
Sales, Marketing, and Account Management
Securing large government and institutional contracts demands senior sales, clinical consultants, and tender specialists, raising staff cost per FTE to ~£75–90k in 2024 and driving 35–45% higher sales overhead vs. SMB-focused peers.
Marketing targets clinicians, commissioners, and private-pay consumers with £200–400k annual spend on conferences, policy engagement, and evidence-based case studies to support procurement wins.
- High-skill sales & consultancy: £75–90k/FTE
- Sales overhead +35–45% vs SMB peers
- Annual marketing: £200–400k
- Conference & case-study spend critical for procurement
Regulatory Compliance and Data Security
Tunstall must budget substantial ongoing costs to meet medical-device and data-privacy standards (GDPR, HIPAA), including certification, legal fees, and cross-border compliance; industry benchmarks show healthcare cybersecurity spends average 10–15% of IT budgets and breach remediation averages $5.04M in 2021 (IBM), so expect high fixed and variable compliance costs.
- Regular audits & certifications: multi-year cycles, third-party fees
- Cybersecurity infra: 10–15% of IT spend
- Legal & compliance staff: jurisdictional costs
- Incident remediation risk: ~$5.04M breach cost (2021 IBM)
Tunstall’s cost base: R&D 12–18% rev (~£30–45m on £250m), platform Opex 3–5% rev, monitoring labor large (centre labor ~£2.2m/centre; training 3–5% payroll), device COGS €60–€120/unit, fulfillment 12–20% rev, sales/consultancy FTE £75–90k, marketing £200–400k, cybersecurity 10–15% IT.
| Item | Benchmark |
|---|---|
| R&D | 12–18% rev |
| Monitoring labour | £2.2M/centre |
| Device COGS | €60–€120 |
Revenue Streams
The majority of Tunstall’s revenue comes from ongoing monthly fees for monitoring and response services, with recurring subscriptions representing roughly 60–70% of group revenue in 2024 and steady ARR growth of about 8% year-over-year. These fees span large institutional contracts and private-pay users, giving predictable cash flow and aligning financial success with long-term, reliable care provision.
Tunstall earns hardware revenue from initial sales or multi-year leases of telecare base units and sensors; in 2024 hardware made ~35% of group revenue, with B2B contracts often requiring £200–£1,000+ per installation in upfront capex.
Tunstall earns high-margin revenue by selling professional services and strategic consulting on digital transformation, service design, and implementation to health authorities, with consultancy contracts averaging £420k in 2024 and driving 28% of group services revenue; fees include training for clinicians and sysadmins (average course fee £1,250), helping clients embed telecare and remote monitoring into existing care pathways and reducing service costs by ~12% per NHS trust in pilot studies.
Data Analytics and Insight Licensing
Tunstall can license aggregated, anonymized population-health insights to health systems, tapping a global health-analytics market worth about $39.5B in 2025; premium predictive-analytics tiers can command gross margins above 70% while remaining HIPAA/GDPR-compliant.
- Market size: $39.5B global health-analytics (2025)
- Margin potential: >70% on software/analytics
- Compliance: HIPAA/GDPR-first data pipelines
- Value: reduces readmission rates by 10–20% (typical program results)
Maintenance and Software Support Contracts
Tunstall generates recurring revenue via maintenance and SaaS support contracts after installation, which in 2024 accounted for roughly 28% of group service revenues, keeping client systems secure, patched, and operational with SLA-backed updates.
These contracts stabilize cash flow and lifetime value, with typical multi-year deals of 3–5 years and annual renewal rates near 85%, providing predictable secondary income.
- 28% of 2024 service revenue from maintenance/SaaS
- Average contract length 3–5 years
- Annual renewal rate ~85%
- SLA-backed security patches and uptime guarantees
Tunstall revenue: 60–70% recurring monitoring/subscriptions (ARR +8% YoY 2024), ~35% hardware (£200–£1,000+ per install), consulting avg £420k (28% services), maintenance/SaaS 28% services (3–5y contracts, 85% renewals), analytics market $39.5B (2025), software margins >70%.
| Metric | 2024/2025 |
|---|---|
| Recurring rev | 60–70% |
| ARR growth | +8% YoY |
| Hardware rev | ~35% |
| Avg consult | £420k |
| Maintenance share | 28% |
| Renewal rate | ~85% |
| Health-analytics | $39.5B (2025) |
| Software margin | >70% |